Peer-reviewed research — Ophthalytics DR detection, validated on real-world fundus images Read the study

Ophthalytics — Wellness Through the Eyes™

Retinal Intelligence for Earlier Detection and Better Health

Advancing eye care through AI, oculomics, and multimodal intelligence—transforming the retina into a gateway for early disease detection and broader health insights.

Awais Bajwa, Founder & CEO

Join us for

CTS Retina · June 13, 2026

Presenter: Awais Bajwa, Founder & CEO

Event Details

Trusted by leading clinicians, researchers & health systems

Beyond the Eye: A New Frontier in Detection

The retina is one of the only places in the body where microvascular and neural structures can be observed directly and noninvasively.

At Ophthalytics, we are advancing the field of oculomics—where retinal imaging extends beyond eye disease to reveal early indicators of systemic health.

By combining AI with multimodal data, we enable earlier risk detection, deeper clinical insights, and more connected care.

This is the future of preventive healthcare—starting with the eye.

Ophthalytics Inc — Product Portfolio

AI-Powered Retinal Intelligence

Wellness Through the Eyes™

Flagship Innovation

Ocula360

Foundational Retinal AI

Ocula360 is our flagship AI engine designed to detect multiple retinal diseases from a single image. Built on a foundational model architecture, it enables scalable screening, advanced DRSS scoring, and future-ready multimodal applications.

From clinical workflows to research environments, Ocula360 transforms retinal imaging into actionable diagnostic intelligence.

Learn more about Ocula360

Core Strengths

From one retinal image to scalable diagnostic intelligence.

Multi-disease detection, explainable AI outputs, DR severity support, and flexible deployment models for providers, payers, eye care, and global screening markets.

Multi-Disease Detection

Detects diabetic retinopathy, AMD, glaucoma indicators, and vascular abnormalities.

DRSS Scoring

Objective, quantitative DRSS severity grading to support disease staging and patient stratification.

Explainable & Multimodal

Lesion-level visualization, confidence outputs, and compatibility with imaging and patient context.

One Company. Four Retinal AI Solutions.

Purpose-built solutions for every point of care.

Ocula360 Multimodal AI Retinal Platform dashboard with 7-field overlay Flagship

Ocula360

Foundational Retinal AI Engine

The platform behind every Ophthalytics solution. Built on a foundational model architecture, Ocula360 detects multiple retinal diseases from a single image and powers DRSS scoring, explainable outputs, and future-ready multimodal applications.

  • Multi-disease detection
  • DRSS severity grading
  • Explainable & multimodal outputs
Learn more
Nsight360 AI-assisted retinal screening on a laptop

Nsight360

AI-Assisted Retinal Screening for Primary Care

Brings retinal screening directly into primary care settings, enabling non-specialists to capture retinal images and receive AI-assisted reports with expert review—closing care gaps and identifying at-risk patients before vision loss occurs.

  • Primary care integration
  • Human + AI workflow
  • Scalable screening programs
Learn more
2nd Opinion AI Diagnostic Support — ultra-widefield scan with 7-field overlay

2nd Opinion

AI-Enhanced Diagnostic Support for Optometry

Built for optometrists and eye care professionals seeking greater confidence in retinal assessments. Provides AI-supported analysis that highlights subtle findings and reduces diagnostic uncertainty without disrupting existing practice workflows.

  • Lesion-level visualization
  • Decision support
  • Workflow integration
Learn more
Ophthal360 autonomous screening dashboard — multi-patient retinal triage and referral overview

Ophthal360

Autonomous AI for Scalable Retinal Screening

Designed for high-volume retinal screening across healthcare systems and large-scale programs. Standardizes screening processes and supports timely referral decisions with minimal manual intervention—built for reach in underserved and resource-limited settings.

  • Autonomous detection
  • High-throughput screening
  • Automated referral logic
Learn more
Atlanta, Georgia, USA Retinal Intelligence for Earlier Detection and Better Health

Who We Help

Supporting providers, systems, and researchers across the care continuum.

Primary Care Providers & Health Systems

Bring retinal screening directly into primary care—enabling earlier detection without specialist dependency.

Optometrists & Eye Care Professionals

Enhance diagnostic confidence with AI-supported interpretation and better visibility into subtle retinal findings.

Insurance Providers & Population Health Programs

Close care gaps, improve screening rates, and support value-based care initiatives.

Pharmaceutical & Clinical Research Organizations

Accelerate patient identification and clinical trial recruitment with advanced retinal intelligence.

Proven Impact in Real-World Care

Our solutions are used by healthcare providers globally to expand access to screening, improve early detection, and prevent vision loss.

“Using Nsight360, we've screened over 250,000 patients and helped prevent thousands of cases of blindness.”

— The Diabetic Center, Pakistan

From Eye Exams to Health Intelligence

Ophthalytics is building a connected ecosystem of retinal AI solutions—designed to improve early detection, expand access to care, and unlock deeper health insights.

Because the future of healthcare starts with seeing risk earlier.

Transform Early Detection with Retinal AI

For inquiries, connect with us on LinkedIn or reach out at +1 862 222 6880 | info@ophthalytics.com